Back to results
US 2022/0008348 A1Published application
Compound delivery systems and methods of production
OwnerMichael Golfettoinventor
Life of this patent
Estimating the term…
Abstract
A delivery composition including a plurality of first nanoparticle excipients each containing an active compound pharmaceutical agent and a plurality of second nanoparticle excipients each containing a modulating agent.
Claims20
A delivery composition, comprising:
- a plurality of first nanoparticle excipients each containing an active compound;
- and
- a plurality of second nanoparticle excipients each containing a modulating agent.
A delivery composition, comprising:
- a plurality of nanoparticle excipients;
- a plurality of microparticle excipients containing cannabidiol;
- water;
- and
- ethanol.
2 more elements
A delivery composition, comprising:
- (a) a dispersible concentrate configured for forming upon contact with an aqueous solution particles of a mean diameter of Jess than about 450 nm;
- the dispersible concentrate further comprising:
- (i) at least one surfactant;
- (ii) at least one solid component at room temperature;
- and
- (iii) an amphiphilic solvent;
- (b) at least one Mitragyna speciosa compound selected from the group consisting of Ajmalicine, Akuammigine, Ciliaphylline, Corynantheidine, Corynoxeine, Corynoxine A, Corynoxine B, Epicatechin, 9-Hydroxycorynantheidine, 7-hydroxymitragynine, Isomitraphylline, Isomitrafoline, Isopteropodine, Isorhynchophylline, Isospeciofoline, Mitraciliatine, Mitragynine, Mitragynine oxindole B. Mitrafoline, Mitraphylline, Mitraversine, Paynantheine, Rhynchophylline, Speciociliatine, Speciofoline, Speciogynine, Speciophylline, Stipulating Tetrahydroalstonine, a corresponding analog, metabolite, isomer and a combination thereof, the at least one Mitragyna speciosa compound present in an amount sufficient to increase the bioavailability of the composition.
4 more elements
Dependencies are inferred from the claim text.